Nektar Therapeutics (NKTR) on GreekSoup https://greeksoup.ai/stocks/us/nktr/ Every dated entry in the public record on Nektar Therapeutics: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Nektar Therapeutics filed S-8: registration statementhttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-10-20:e6f5a15938Tue, 20 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: short interest 6,997,725 shares at the 15 October 2026 settlement, 3.52 days to coverhttps://greeksoup.ai/stocks/us/nktr/short-interest/us:NKTR:short-interest:2026-10-15:dab49f93fdThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nektar Therapeutics filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-10-01:10a9be76daThu, 01 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: short interest 6,968,325 shares at the 30 September 2026 settlement, 3.76 days to coverhttps://greeksoup.ai/stocks/us/nktr/short-interest/us:NKTR:short-interest:2026-09-30:db5dc691ddWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Schedule 13G/A filed by Two Seas Capital LP, 9.8% of the classhttps://greeksoup.ai/stocks/us/nktr/holders/us:NKTR:schedule-13:2026-09-28:6b8425d182Mon, 28 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Nektar Therapeutics filed 8-K: other eventshttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-09-25:0de4af08ecFri, 25 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: short interest 5,735,633 shares at the 15 September 2026 settlement, 7.57 days to coverhttps://greeksoup.ai/stocks/us/nktr/short-interest/us:NKTR:short-interest:2026-09-15:02844b26f0Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nektar Therapeutics filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-09-08:09b238a172Tue, 08 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: short interest 6,068,214 shares at the 31 August 2026 settlement, 11.45 days to coverhttps://greeksoup.ai/stocks/us/nktr/short-interest/us:NKTR:short-interest:2026-08-31:853f259d3bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Zalevsky Jonathan (Chief R&D Officer) sold 186 shares at $71.98 on 18 August 2026, $13,388https://greeksoup.ai/stocks/us/nktr/insiders/us:NKTR:insider:2026-08-20:ebb70492feThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Robin Howard W (President & CEO) sold 418 shares at $71.98 on 18 August 2026, $30,088https://greeksoup.ai/stocks/us/nktr/insiders/us:NKTR:insider:2026-08-20:bc52d5cb4aThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Form 144, Zalevsky Jonathan plans to sell 186 shares worth $13,388 around 18 August 2026https://greeksoup.ai/stocks/us/nktr/planned-sales/us:NKTR:planned-sale:2026-08-18:5905410b27Tue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Form 144, ROBIN HOWARD W plans to sell 418 shares worth $30,087 around 18 August 2026https://greeksoup.ai/stocks/us/nktr/planned-sales/us:NKTR:planned-sale:2026-08-18:0c571ca6d0Tue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Nektar Therapeutics Q2 FY2026 results: revenue $10 million, net income -$41 millionhttps://greeksoup.ai/stocks/us/nktr/results/fy2026-q2/us:NKTR:result:2026-08-14:24307e98b6Fri, 14 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Nektar Therapeutics filed S-8: registration statementhttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-08-14:18a12209fdFri, 14 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nektar Therapeutics filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-08-14:46d9e9a8f1Fri, 14 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Schedule 13G/A filed by Two Seas Capital LP, 9.1% of the classhttps://greeksoup.ai/stocks/us/nktr/holders/us:NKTR:schedule-13:2026-08-14:7ee2d29914Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: Schedule 13G/A filed by BIOTECHNOLOGY VALUE FUND L P, 7.1% of the classhttps://greeksoup.ai/stocks/us/nktr/holders/us:NKTR:schedule-13:2026-08-14:1be71246fbFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Nektar Therapeutics: short interest 6,168,872 shares at the 14 August 2026 settlement, 10.43 days to coverhttps://greeksoup.ai/stocks/us/nktr/short-interest/us:NKTR:short-interest:2026-08-14:461d975218Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nektar Therapeutics filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/nktr/filings/us:NKTR:filing:2026-08-13:33fd046826Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>